A new study led by Christine Veenstra, M.D., MSHP, at the University of Michigan Health Rogel Cancer Center uncovers important insights for cancer patients with specific genetic variants. The findings challenge common assumptions about how these mutations impact cancer survival. Want to know how this research could change the way we think about genetic testing and cancer outcomes? Keep reading to find out more.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.